alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

Section 1350 Certification  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18,
United States Code), each of the undersigned officers of Symmetry Medical Inc., a Delaware corporation (the "Corporation"), does hereby certify that:

The
Annual Report on Form 10-K for the year ended December 30, 2006 (the "Form 10-K") of the Corporation fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition
and results of operations of the Corporation.

Dated:    April 23,
2008

| | /s/BRIAN S. MOOREBrian S. Moore
Chief Executive Officer
| | -------------------------------------------------------
| | /s/FRED L. HITEFred L. Hite
Chief Financial Officer    

---



QuickLinks
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 11-1549

KIMBERLY ANN SHREVE,

Plaintiff - Appellant,

v.

KRISTEN LYNN FETTER; TINA TANT HOAGLAND; C. COLON 

WILLOUGHBY, JR.,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern 

District of North Carolina, at Raleigh. Malcolm J. Howard,

Senior District Judge. (5:11-cv-00157-H)

Submitted: July 28, 2011 Decided: August 1, 2011

Before SHEDD, AGEE, and DIAZ, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Kimberly Ann Shreve, Appellant Pro Se. 

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Kimberly Ann Shreve appeals the district court’s order 

adopting the magistrate judge’s recommendation and dismissing 

her civil action. On appeal, we confine our review to the 

issues raised in the Appellant’s brief. See 4th Cir. R. 34(b). 

Because Shreve’s informal brief does not challenge the basis for 

the district court’s disposition, Shreve has forfeited appellate 

review of the court’s order. Accordingly, we affirm the 

district court’s judgment. We dispense with oral argument 

because the facts and legal contentions are adequately presented 

in the materials before the court and argument would not aid the 

decisional process.

AFFIRMED
MEP Advisory Board Meeting 

Tuesday, March 3, 2020

NIST Gaithersburg Campus

Portrait Room, Building 101

100 Bureau Drive, Gaithersburg, MD 20899

AGENDA (Draft)

8:15 a.m.–8:20 a.m.

5 minutes

Meeting Opening/Logistics Cheryl Gendron, NIST MEP

8:20 a.m.–8:40 a.m.

20 minutes

Welcome and Introductions

Opening Remarks

Welcome from NIST Leadership

Board and Audience Introductions

Bernadine Hawes, Chair, 

MEP Advisory Board 

Dr. Walter Copan, NIST

Carroll Thomas, NIST MEP

8:40 a.m.–9:10 a.m.

30 minutes

Director’s Update 

Board Feedback and Discussion

Carroll Thomas

9:10 a.m.–9:35 a.m.

25 minutes

MEP National NetworkTM Strategic 

Plan 2017-2022 Update

Board Feedback and Discussion

Carroll Thomas

9:35 a.m.-10 a.m.

25 minutes

Presentation: Overview NIST 

Engineering Laboratory

Board Feedback and Discussion

Dr. Joannie Chin, NIST Engineering 

Laboratory

10 a.m.-10:15 a.m.

15 minutes

Break

10:15 a.m.-10:45 a.m.

30 minutes

Presentation: MEP National Network 

Branding and Communications

Board Feedback and Discussion

Chancy Lyford, NIST MEP

Ben Vickery, NIST MEP

10:45 a.m.-11:35 a.m.

50 minutes

Working Group Update: Supply 

Chain Development Working Group

Board Feedback and Discussion 

Matt Newman, Vice Chair, 

MEP Advisory Board

Dave Stieren, NIST MEP

11:35 a.m.-12:05 p.m.

30 minutes

Working Group Update: Executive 

Committee Working Group

Board Feedback and Discussion

Bernadine Hawes

Carroll Thomas

Cheryl Gendron

12:05 p.m.-12:30 p.m.

25 minutes

Wrapup/Public Comments Bernadine Hawes

Carroll Thomas

Rev. 2/5/2020 Agenda Subject to Change

Meeting Open to the Public/Registration Required

Anyone planning to attend the MEP Advisory Board meeting on NIST Gaithersburg Campus must be 

preregistered in NIST’s visitor registration system. Please provide your name (as it appears on your ID), 

citizenship (U.S. or foreign), company/organization, email address and phone number to Cheryl Gendron 

(Cheryl.Gendron@nist.gov ) no later than Tuesday, Feb. 25, 2020, 5 p.m. Eastern Standard Time.
<TABLE> <S> <C>

<ARTICLE> 7
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE CONDENSED
CONSOLIDATED STATEMENT OF OPERATIONS AND BALANCE SHEETS (UNAUDITED) AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<EXCHANGE-RATE>                                      1
<DEBT-HELD-FOR-SALE>                           798,708
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                      13,679
<MORTGAGE>                                      93,884
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 986,244
<CASH>                                          12,908
<RECOVER-REINSURE>                                   0
<DEFERRED-ACQUISITION>                         439,176
<TOTAL-ASSETS>                               7,312,027
<POLICY-LOSSES>                              1,009,382
<UNEARNED-PREMIUMS>                              5,855
<POLICY-OTHER>                                      15
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                160,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,500
<OTHER-SE>                                     451,376
<TOTAL-LIABILITY-AND-EQUITY>                 7,312,027
<PREMIUMS>                                           0
<INVESTMENT-INCOME>                             42,671
<INVESTMENT-GAINS>                              (2,215)
<OTHER-INCOME>                                  69,398
<BENEFITS>                                     128,856
<UNDERWRITING-AMORTIZATION>                     19,699
<UNDERWRITING-OTHER>                           (51,522)
<INCOME-PRETAX>                                  7,269
<INCOME-TAX>                                     3,718
<INCOME-CONTINUING>                              3,551
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,551
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0








</TABLE>
[Federal Register Volume 79, Number 221 (Monday, November 17, 2014)]
[Proposed Rules]
[Page 68395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-27038]



[[Page 68395]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 216

[Docket No. FDA-1999-N-0194]
RIN 0910-AH08


Additions and Modifications to the List of Drug Products That 
Have Been Withdrawn or Removed From the Market for Reasons of Safety or 
Effectiveness; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; withdrawal of previous proposed rule; 
correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
document entitled ``Additions and Modifications to the List of Drug 
Products That Have Been Withdrawn or Removed From the Market for 
Reasons of Safety or Effectiveness'' that appeared in the Federal 
Register of July 2, 2014. The document proposed amending FDA's 
regulations to revise the list of drug products that may not be 
compounded under the exemptions provided by the Federal Food, Drug, and 
Cosmetic Act because the drug products have been withdrawn or removed 
from the market after the drug products or components of such drug 
products were found to be unsafe or not effective. The document also 
withdrew the previous proposed rule regarding additions to this list 
(see the Federal Register of January 4, 2000). The document was 
published with an incorrect RIN number. This document corrects the 
error.

DATES: The proposed rule published July 2, 2014 (79 FR 37687) is 
corrected as of November 17, 2014.

FOR FURTHER INFORMATION CONTACT: Edisa Gozun, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 51, Rm. 5199, Silver Spring, MD 20993-0002, 301-
796-3110.

SUPPLEMENTARY INFORMATION: In FR Doc. 2014-15371, appearing on page 
37687 in the Federal Register of July 2, 2014 (79 FR 37687), FDA is 
making the following correction:
    1. On page 37687, in the first column, the RIN number heading is 
corrected to read ``RIN 0910-AH08''.
    2. On page 37687, in the second column, the RIN number under the 
ADDRESSES heading is corrected to read ``RIN 0910-AH08''.
    3. On page 37687, in the second column, the RIN number under the 
Instructions sub-heading is corrected to read ``RIN 0910-AH08''.

    Dated: November 10, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-27038 Filed 11-14-14; 8:45 am]
BILLING CODE 4164-01-P
Dear Sir: 

I am writing to provide comments on the above subject matter. The Institute of 

Medicine (IOM) completed a study in 2010 examining the conformity assessment that 

currently exists for personal protective technologies used in the workplace. The IOM 

study concluded that worker safety and health would be better served by having the 

National Institute of Occupational Safety and Health (NIOSH) assist in coordinating the 

various governmental and voluntary standards that currently exist in this area and to 

develop a risk model to determine what the role of government should be in the 

conformity assessment of personal protective technologies used by workers. The report 

can be found at: http://www.iom.edu/Reports/2010/Certifying-Personal-ProtectiveTechnologies-Improving-Worker-Safety.aspx

My comment and recommendation is that NIOSH’s role in the conformity assessment 

process for personal protective equipment would be an excellent case study for NIST to 

examine. Furthermore, NIST could contrast this process with the process used by 

NIOSH (as mandated by Federal law) to certify respiratory protection. 

I had the privilege to chair the IOM study on conformity assessment of personal 

protective technologies in 2010, but my comment and recommendation is being made 

as an individual and not on behalf of the IOM. 

Sincerely, 

Howard J. Cohen, Ph.D., CIH
**EXHIBIT 32.2**
**CERTIFICATION**
     Pursuant to 18 U.S.C. Section 1350, the undersigned officer of VornadoOperating Company (the “Company”) hereby certifies, to such officer’sknowledge, that the Company’s Quarterly Report on Form 10-Q for the quarterended June 30, 2003 (the “Report”) fully complies with the requirements ofSection 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934and that the information contained in the Report fairly presents, in allmaterial respects, the financial condition and results of operations of theCompany.   August 11, 2003      /s/ JOSEPH MACNOWName: Joseph Macnow  Title:   Chief Financial Officer
##### 



EXHIBIT 32.2


CERTIFICATION OF


PRINCIPAL EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350


(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)






| |                                                                                                                                                                                                                                                                                                                   
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) such Annual Report on Form 10-K of Odimo
    Incorporated for the fiscal year ended December 31, 2004,
    fully complies with the requirements of Section 13(a) or
    15(d) of the Securities Exchange Act of 1934, as
    amended; and                                                                     
|
| | (2) the information contained in such Annual Report on
    Form 10-K of Odimo Incorporated for the fiscal year ended
    December 31, 2004, fairly presents, in all material
    respects, the financial condition and results of operations of
    Odimo Incorporated at the dates and for the periods indicated.





| |                              
| | -----------------------------
| | /s/ Amerisa Kornblum         
| |                              
| | Amerisa Kornblum             
| | Chief Financial Officer      
| | (Principal Financial Officer)
#### Wells et al., Appellees, *v.*Friend et al., Appellants.

(No. 1991

Decided December 1, 1948.)

*Messrs. Harslvman & Young*and *Mr. Mason Doug'ilass,*for the motion.

*Messrs. Beigel é Mahrt,*contra.

By the Court.

This appeal is submitted on motion •of plaintiffs, appellees herein, to dismiss the appeal for failure to file assignments of error and brief with-in 50 days after filing notice of intention to appeal on •questions of law, as required by Rule VII of the Courts •of Appeals.

The motion to dismiss is supported by the record .and it is hereby sustained.

*Motion sustained.*

Wiseman, P. J., Miller and Hornbeck, JJ., concur.
Alicia Carriquiry

Iowa State University 
• Alicia Carriquiry, Iowa State University (Director)

• Stephen Fienberg, Carnegie Mellon University 

• Karen Kafadar, University of Virginia 

• Hal Stern, University of California Irvine 

Program Coordinator: 

• Stacy Renfro, Iowa State University

Principal Investigators
• CSAFE is an umbrella organization that includes:

• The NIST Center of Excellence in Forensic Science

• The Midwest Forensic Resource Center (MFRC)

• The NIST Center of Excellence is the major partner in 

CSAFE.

Organization
We have a three-fold mission:

• To carry out research in the statistical and probabilistic 

foundations of pattern evidence and digital evidence

• To engage the community of forensic practitioners

• To develop training in statistics and probability for 

practitioners, the legal profession and other stake 

holders

Mission of CSAFE
Focus Areas

Human 

Factors

Statistical 

Foundations

• Handwriting

• Firearms & Toolmarks

• Shoeprints & Treadmarks

• Fingerprints

• Digital Forensics

• Blood Pattern Analysis

Training 

& 

Education
• The NIST Center of Excellence is a close partner of NIST.

• Scientists in CSAFE work with NIST collaborators to carry out its 

mission.

• Partnership includes:

• Research collaboration

• Visits from CSAFE to NIST and vice versa

• Shared on-line resources for practitioners and other researchers.

Partnership with NIST
Collaboration

• Medical Professionals

• Lawyers 

• Judges

• Universities

• International Partners

• Forensic Practitioners 

• Subject Matter Experts

• Law Enforcement 
• Sensofar: Development of imaging algorithm for bullets, breech 

face and pin impressions to facilitate forensic analyses.

• American Bar Association (ABA): Statistics instruction for judges.

• Ames Laboratory: Data collection in different areas.

• DOJ: Forensic science disciplines review.

• DFSC: Review of new approaches for latent fingerprint analyses.

• Palm Beach (FL) and Tri-County Regional (MN) laboratories: 

Statistics primer for forensic providers.

Recent collaborations
• We provide a venue where scientists in different disciplines, as 

well as practitioners, can address important forensic problems.

• Short or long visits to any of the partner institutions can be 

arranged.

• Summer internships for undergraduate and graduate students, 

as well as post-doctoral positions are available.

• For information, please contact:

Stacy Renfro: srenfro@iastate.edu

Or visit www.forensicstats.org

Invitation to join us!
UNITED STATES DISTRICT COURT

FOR THE Northern District of Illinois − CM/ECF LIVE, Ver 6.3.3

Eastern Division

Stacy Childress

Plaintiff,

v. Case No.: 1:20−cv−02687

Honorable Joan H. Lefkow

Empire Today, LLC

Defendant.

NOTIFICATION OF DOCKET ENTRY

This docket entry was made by the Clerk on Friday, November 6, 2020:

 MINUTE entry before the Honorable Joan H. Lefkow: Pursuant to the stipulation

of dismissal [21], this case is dismissed without prejudice with each party to bear its own

costs and fees. Civil case terminated. Mailed notice (ags)

ATTENTION: This notice is being sent pursuant to Rule 77(d) of the Federal Rules of

Civil Procedure or Rule 49(c) of the Federal Rules of Criminal Procedure. It was

generated by CM/ECF, the automated docketing system used to maintain the civil and

criminal dockets of this District. If a minute order or other document is enclosed, please

refer to it for additional information.

For scheduled events, motion practices, recent opinions and other information, visit our

web site at www.ilnd.uscourts.gov.

Case: 1:20-cv-02687 Document #: 22 Filed: 11/06/20 Page 1 of 1 PageID #:81
EXHIBIT 32


                        CERTIFICATION OF PERIODIC REPORT
            Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
                             18 U.S.C. Section 1350

I, the undersigned, certify pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:


         o        the  quarterly  report on Form 10-QSB of  Perfisans  Holdings,
                  Inc.  (the  "Company")  for the period  ended March 31,  2004,
                  fully complies with the requirements of Section 13(a) or 15(d)
                  of the Securities Exchange Act of 1934; and

         o        the information  contained in the Form 10-QSB fairly presents,
                  in all material respects,  the financial condition and results
                  of operations of the Company.



Date:   May 18, 2004


                          /s/ To-Hon Lam
                          --------------------------------------
                          To-Hon Lam
                          Chief Executive Officer & Principal Accounting Officer
Mobile Device Forensics in 

Academia

How we find out what we need to find out.
Mobile Device Forensics in Academia
Academia

ac·a·de·mi·a /ˌakəˈdēmēə/ 

Noun. Origin 1945–50; Neo-Latin

the environment concerned with the pursuit of 

Research, Education, and Scholarship.
"Study the past if you would 

define the future...." 

- Confucius


In 2002...

Michael Burnette

Palm DD (PDD) – Joe Grand Joe 

Grand

ROM.txt RAM.txt
2 years later...

2004
Rick Ayers & Wayne Jansen

August 2004 
Tools and Operating Systems – THEN...

Barrie Mellars
AT Commands
Eoghan Casey

Mobile Forensics in Academia

• SIMs

• Shielding

• SMS

• GPS

• Hashing

• Images/Videos

• Legal

• Operating Systems

• Android

• BlackBerry

• iOS

• Maemo

• Symbian

• WebOS

• Windows

• Other... 
SIM
Shielding
SMS
GPS
Hashing
Images/Videos
Legal
Legal
Operating Systems
Android
BlackBerry
BlackBerry
iOS

Jonathan Zdziarski

Sean Morrisey

Ryan Kubasiak
Maemo
Symbian
WebOS
Windows
Comparing OS’s
Comparing OS’s
and a few others 

worth mentioning...

Not found in the Journals...
Levels of Forensics
Levels of Forensics
Process for Examination
JTAG
Academic Journals 

and Conferences
Australian Digital Forensics Conference 

– Edith Cowan University

http://ro.ecu.edu.au/adf/
Digital Forensic Reasearch Work Shop

http://www.dfrws.org/2014/cfp.shtml
Digital Investigation

http://www.journals.elsevier.com/digitalinvestigation/
Hawaii International Conference

on Systems Sciences

http://www.hicss.hawaii.edu/
International Conference on Digital 

Forensics an Cyber Crime

http://d-forensics.org/2014/show/home
International Journal of Digital Crime and 

Forensics

http://www.igiglobal.com/journal/international-journaldigital-crime-forensics/1112
International Journal of Digital Evidence

Archive.org – IJDE.org
International Journal of Electronic 

Security and Digital Forensics

http://www.inderscience.com/jhome.php?j

code=ijesdf
International Federation for Information 

Processing

http://www.ifip.org/
Journal of Digital Forensic Practice

http://www.tandfonline.com/toc/udfp20/cu

rrent#.U588efldWac
The Journal of Digital Forensics, Security 

and Law

http://www.adfsl.org/journal.htm
Small Scale Digital Device Forensics 

Journal

http://www.ssddfj.org


A Call to Arms

An Invitation for Research
Anti-Forensics
App Forensics
Chinese Knockoffs
The Cloud
Flasher Devices
Tool Validation
Triage
User Knowledge
The Vendor Tools

Ad Hoc Reactive Methodology

a. User Has an Issue

b. Emails Problem to Vendor

c. Fixes Issue in Next Revision

Validation and Verification

How do we know what we don’t know!
Drinking the Kool-Aid

Research:

• Prove or disprove a hypothesis 

• Learn new facts 

• Advance the common body of 

knowledge

We have a need to know!
One more thing...

for Steve...
Historical Review
Mobile Forensics Tools

From A-Z





Research is 

sometimes 

difficult...
But, 

research is 

necessary!

Thank you!

www.mislan.com